Meet The Attys Guiding Omega Therapeutics Through Ch. 11
By Emlyn Cameron · February 11, 2025, 5:22 PM EST
Biotechnology company Omega Therapeutics, which hit Chapter 11 in Delaware on Monday with more than $140 million of debt and a restructuring agreement with an affiliate of its controlling stockholder, has...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login